06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

  • ID: 2191572
  • June 2012
  • Region: Global
  • 40 Pages
  • Life Science Intelligence
1 of 3

This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012.

All companies include technology, market(s), key executive, and contact information.

Two- to three-page executive summaries are provided on most of the companies.

Executive summaries typically include:

- Company Contact Information
- Company Overview (structure, size, year founded, etc.)
- Competitive Landscape
- Technological Advantage
- Stage of Development
- Target Markets
- Financial Summary and Sales Forecasts
- Financing & Partnering Needs
- IP Position & Status
- Management Team
- Exit Strategy
- More

Coverage includes innovations in a broad spectrum of medical technology areas including:

- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies

Note: Product cover images may vary from those shown
2 of 3

- The d-OSAB platform technology, used to treat ischemic stroke by delivering a precise, measured dose of oxidative stressor and comprising a monitoring system that determines the amount of stressor absorbed as well as a disposable device that maximizes contact with the fluid or blood

- A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells

- The Hemolung Respiratory Assist System, a respiratory dialysis product comprising a contoller, cartridge, and catheter; intended to replace or supplement mechanical ventilation in Intensive Care Unit (ICU) patients with acute hypercapnic respiratory failure

- Nanotechnology-based Point-of-Care products for the collection and screening of blood, urine, or oral fluids

- 1. Vascular staplers for open surgery of abdominal aortic aneurysms (AAAs) or aorto-biliac/femoral bypasses 2. Endovascular staplers for fixation of any current stent-grafts 3. Staplers for Critical Limb Ischemia surgery, aiming to replace Femoro-Popliteal bypasses

- Ultrasound-guided cryothermally enhanced devices used to facilitate the site-specific C(2) (Cryo-Chemo) Cancer Ablation Procedure, which delivers newly developed proprietary therapies to cancer sites while avoiding toxic side effects

- A three-layered biological patch, called the LeucoPatch, which can be derived without additives from the patient's blood within 20 minutes; used for chronically non-healing and debilitating wounds

- The ViSi Mobile System, a comprehensive vital signs monitoring platform for bedside, ambulatory, or transport applications

- The CoolTools family of products, which target support/microcatheterization, local vascular drug delivery, and selective hypothermia for the treatment of ischemic brain injury (e.g., stroke, cardiac arrest, trauma)

- Intraurethral devices including a prostatic urethral stent and a urethral measurement device to enable the selection of proper stent sizes

- Biological therapies targeting bone loss, blood and muscular weakness disorders, cancer, and rheumatoid arthritis

- Corneal inlay for the treatment of near vision loss

- Therapeutics aimed at cellular targets in cancer metabolism, e.g., IDH1, IDH2, and PKM2

- Therapeutic antibodies discovered and optimized using somatic hypermutation (SHM)

- Offers technologies for drug delivery systems, including complex release products, fast-dispersing dosage forms, and biodegradable polymers for custom release profiles in implants

- Targeted nanoparticles that selectively accumulate at disease sites and minimize the damage to healthy tissues for the treatment of cancer, cardiovascular conditions, and inflammatory diseases

- Develops polymer composite products for biomedical applications, including clear braces for orthodontic patients

- A continuous glucose monitoring device

- Diagnostic assays for joint fluid analysis; these technologies use a lateral flow immunoassay designs and are used to rapidly detect the causes of joint pain

- An electrical stimulation device that targets the weak/dysfunctional lower esophageal sphincter in order to treat severe Gastro Esophageal Reflux Disease (GERD)

- A glaucoma-detection technology that superimposes images of the posterior pole of the eye to show changes over time

- Portable oxygen concentrator for active respiratory patients

- Microfluidic automation systems used for rapid DNA analysis

- A neurostimulation device for the treatment of lower back pain

- A highly-articulated multi-link robot that enables the performance of minimally invasive surgery

- Discreet sensors placed throughout the home for the purpose of monitoring elderly individuals

- Innovative protein, peptide, and antibody drug candidates for the treatment of cardiovascular disease, diabetes, muscle wasting, and obesity

- Lenses that address vision problems associated with higher-order aberrations of the eye, improving vision, contrast acuity, nighttime driving vision, and color dullness

- Innovative therapeutics for cardiovascular disease and autoimmune/inflammatory diseases that are based on targets with established proof of concept and can offer advantages over existing therapies

- A pain management patch comprising a dressing and skin-friendly adhesive

- Orthopedic devices

- A cost-effective, efficient system for the production of ophthalmic lenses

- New antibacterial drugs that target multi-drug resistant pathogens

- Low-cost, portable ultrasound systems that offer bone and 3D imaging capabilities

- A fully-implantable continuous glucose monitoring system that utilizes fluorescence sensing technology

- Orthopedic plate and screw systems for large and small bone fragments

- A novel, short-peripheral intravenous (IV) catheter featuring a pre-assembled, closed design with high-pressure extension tubing, a multi-use flow control clamp, and stabilization technology

- Portable x-ray technologies for medical applications

- External radiation therapy technology

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.


If you have a more general question about our products please try our



Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S